Zimmer Biomet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zimmer Biomet and other ETFs, options, and stocks.

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. 

CEO
Ivan Tornos
CEOIvan Tornos
Employees
17,000
Employees17,000
Headquarters
Warsaw, Indiana
HeadquartersWarsaw, Indiana
Founded
1927
Founded1927
Employees
17,000
Employees17,000

ZBH Key Statistics

Market cap
19.25B
Market cap19.25B
Price-Earnings ratio
27.17
Price-Earnings ratio27.17
Dividend yield
1.00%
Dividend yield1.00%
Average volume
2.83M
Average volume2.83M
High today
$97.76
High today$97.76
Low today
$96.31
Low today$96.31
Open price
$96.80
Open price$96.80
Volume
2.61M
Volume2.61M
52 Week high
$114.44
52 Week high$114.44
52 Week low
$84.59
52 Week low$84.59

Stock Snapshot

As of today, Zimmer Biomet(ZBH) shares are valued at $97.15. The company's market cap stands at 19.25B, with a P/E ratio of 27.17 and a dividend yield of 99.5%.

As of 2026-02-18, Zimmer Biomet(ZBH) stock has fluctuated between $96.31 and $97.76. The current price stands at $97.15, placing the stock +0.9% above today's low and -0.6% off the high.

The Zimmer Biomet(ZBH)'s current trading volume is 2.61M, compared to an average daily volume of 2.83M.

In the last year, Zimmer Biomet(ZBH) shares hit a 52-week high of $114.44 and a 52-week low of $84.59.

In the last year, Zimmer Biomet(ZBH) shares hit a 52-week high of $114.44 and a 52-week low of $84.59.

ZBH News

Simply Wall St 1d
A Look At Zimmer Biomet Valuation After Earnings Beat And Robotics Progress

Advertisement Why Zimmer Biomet stock is back in focus Zimmer Biomet Holdings (ZBH) is back on investors radar after fourth quarter and full year 2025 results...

A Look At Zimmer Biomet Valuation After Earnings Beat And Robotics Progress
Simply Wall St 5d
Zimmer Biomet Reshapes U.S. Sales Model As ROSA Knee Gains Ground

Zimmer Biomet Holdings (NYSE:ZBH) has launched a major reorganization of its U.S. salesforce, targeting a fully dedicated and specialized structure by 2027. Th...

Zimmer Biomet Reshapes U.S. Sales Model As ROSA Knee Gains Ground
TipRanks 6d
Zimmer Biomet price target lowered to $100 from $104 at Barclays

Barclays analyst Matt Miksic lowered the firm’s price target on Zimmer Biomet (ZBH) to $100 from $104 and keeps an Underweight rating on the shares. Published...

Analyst ratings

55%

of 31 ratings
Buy
32.3%
Hold
54.8%
Sell
12.9%

People also own

Based on the portfolios of people who own ZBH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.